Novel drug-like RAR-Beta agonist induces BRCA1 to prevent neuropathic pain

Published: 12 Sep 2019 | Version 3 | DOI: 10.17632/kjvs5vgkbf.3
Contributor(s):

Description of this data

Differential gene expression analysis (RNA-sequencing) assessed in the SC from L5-SNL rats and non-injured rats, treated with vehicle or C286. Raw counts per gene (Raw counts.zip file) were normalized (quantile normalization; Normaliez counts.zip), then used for a differential gene expression analysis relative to the sample non-injured + vehicle (Diff_expression_DESeq2.zip). In addition, we have included herein a supplementary Table containing Gene Ontology (GO) terms per gene co-expression paths issued from the differential expression analysis. Notice that GO terms are described by their confidence of enrichment, expressend on "-10*log10(p-value).

Experiment data files

Latest version

  • Version 3

    2019-09-12

    Published: 2019-09-12

    DOI: 10.17632/kjvs5vgkbf.3

    Cite this dataset

    Mendoza-Parra, Marco Antonio; Goncalves, Maria B.; Corcoran, Jonathan (2019), “Novel drug-like RAR-Beta agonist induces BRCA1 to prevent neuropathic pain”, Mendeley Data, v3 http://dx.doi.org/10.17632/kjvs5vgkbf.3

Statistics

Views: 50
Downloads: 13

Previous versions

Compare to version

Institutions

King's College London, Genoscope Centre National de Sequencage

Categories

Transcriptomics

Licence

CC BY 4.0 Learn more

The files associated with this dataset are licensed under a Creative Commons Attribution 4.0 International licence.

What does this mean?

This dataset is licensed under a Creative Commons Attribution 4.0 International licence. What does this mean? You can share, copy and modify this dataset so long as you give appropriate credit, provide a link to the CC BY license, and indicate if changes were made, but you may not do so in a way that suggests the rights holder has endorsed you or your use of the dataset. Note that further permission may be required for any content within the dataset that is identified as belonging to a third party.

Report